Williams E, Egede L, Oates J, Dismuke C, Ramakrishnan V, Faith T
Trials. 2019; 20(1):529.
PMID: 31443732
PMC: 6708151.
DOI: 10.1186/s13063-019-3580-4.
Reddy V, Akehurst R, Gavaghan M, Amorosi S, Holmes Jr D
J Am Heart Assoc. 2019; 8(13):e011577.
PMID: 31230500
PMC: 6662368.
DOI: 10.1161/JAHA.118.011577.
Reddy V, Akehurst R, Amorosi S, Gavaghan M, Hertz D, Holmes Jr D
Stroke. 2018; 49(6):1464-1470.
PMID: 29739915
PMC: 5976225.
DOI: 10.1161/STROKEAHA.117.018825.
Wolf L, Ejiofor J, Wang Y, Hunink M, Losina E, Haider A
Ann Surg. 2017; 269(2):358-366.
PMID: 29194083
PMC: 7996320.
DOI: 10.1097/SLA.0000000000002507.
Meregaglia M, Cairns J
Health Qual Life Outcomes. 2017; 15(1):174.
PMID: 28865475
PMC: 5581467.
DOI: 10.1186/s12955-017-0748-z.
Cost-effectiveness of endovenous laser ablation of the great saphenous vein in patients with uncomplicated primary varicosis.
Luebke T, Brunkwall J
BMC Cardiovasc Disord. 2015; 15:138.
PMID: 26510413
PMC: 4625802.
DOI: 10.1186/s12872-015-0130-1.
Cost-Effectiveness of a Biopsy-Based 8-Protein Prostate Cancer Prognostic Assay to Optimize Treatment Decision Making in Gleason 3 + 3 and 3 + 4 Early Stage Prostate Cancer.
Roth J, Ramsey S, Carlson J
Oncologist. 2015; 20(12):1355-64.
PMID: 26482553
PMC: 4679086.
DOI: 10.1634/theoncologist.2015-0214.
Clinical outcomes and cost effectiveness of two aftercare models provided by general physicians and nurses to patients with severe mental illness.
Malakouti S, Mirabzadeh A, Nojomi M, Ahmadi Tonkaboni A, Nadarkhani F, Mirzaie M
Med J Islam Repub Iran. 2015; 29:196.
PMID: 26157714
PMC: 4476229.
Cost-utility analysis of nonalcoholic steatohepatitis screening.
Zhang E, Wartelle-Bladou C, Lepanto L, Lachaine J, Cloutier G, Tang A
Eur Radiol. 2015; 25(11):3282-94.
PMID: 25994191
PMC: 4836892.
DOI: 10.1007/s00330-015-3731-2.
Cost-effectiveness of a 14-gene risk score assay to target adjuvant chemotherapy in early stage non-squamous non-small cell lung cancer.
Roth J, Billings P, Ramsey S, Dumanois R, Carlson J
Oncologist. 2014; 19(5):466-76.
PMID: 24710309
PMC: 4012962.
DOI: 10.1634/theoncologist.2013-0357.
Visualization and dynamics of multidimensional health-related quality-of-life-adjusted overall survival: a new analytic approach.
Andrei A, Grady K
Qual Life Res. 2014; 23(5):1411-9.
PMID: 24395525
PMC: 4032617.
DOI: 10.1007/s11136-013-0608-1.
Mapping the FACT-G cancer-specific quality of life instrument to the EQ-5D and SF-6D.
Teckle P, McTaggart-Cowan H, van der Hoek K, Chia S, Melosky B, Gelmon K
Health Qual Life Outcomes. 2013; 11:203.
PMID: 24289488
PMC: 4220776.
DOI: 10.1186/1477-7525-11-203.
Mapping CushingQOL scores to EQ-5D utility values using data from the European Registry on Cushing's syndrome (ERCUSYN).
Badia X, Roset M, Valassi E, Franz H, Forsythe A, Webb S
Qual Life Res. 2013; 22(10):2941-50.
PMID: 23539468
PMC: 3853865.
DOI: 10.1007/s11136-013-0396-7.
Cost-effectiveness and economic impact of the KineSpring ® Knee Implant System in the treatment for knee osteoarthritis.
Li C, Seeger T, Auhuber T, Bhandari M
Knee Surg Sports Traumatol Arthrosc. 2013; 21(11):2629-37.
PMID: 23397420
DOI: 10.1007/s00167-013-2427-x.
Quality-of-life loss of people admitted to burn centers, United States.
Miller T, Bhattacharya S, Zamula W, Lezotte D, Kowalske K, Herndon D
Qual Life Res. 2012; 22(9):2293-305.
PMID: 23224665
DOI: 10.1007/s11136-012-0321-5.
Estimating preference-based EQ-5D health state utilities or item responses from neuropathic pain scores.
Gu N, Bell C, Botteman M, Ji X, Carter J, van Hout B
Patient. 2012; 5(3):185-97.
PMID: 22765255
DOI: 10.1007/BF03262491.
Mapping health status measures to a utility measure in a study of nursing home residents with advanced dementia.
Goldfeld K, Hamel M, Mitchell S
Med Care. 2012; 50(5):446-51.
PMID: 22635251
PMC: 3549579.
DOI: 10.1097/MLR.0b013e3182407e0d.
Evaluation of utility in shoulder pathology: Correlating the American Shoulder and Elbow Surgeons and Constant scores to the EuroQoL.
Bafus B, Hughes R, Miller B, Carpenter J
World J Orthop. 2012; 3(3):20-4.
PMID: 22550620
PMC: 3329619.
DOI: 10.5312/wjo.v3.i3.20.
Estimating utilities for chronic kidney disease, using SF-36 and SF-12-based measures: challenges in a population of veterans with diabetes.
Rajan M, Lai K, Tseng C, Qian S, Selim A, Kazis L
Qual Life Res. 2012; 22(1):53-64.
PMID: 22392523
DOI: 10.1007/s11136-012-0139-1.
Quality-adjusted life years lost to road crash injury: updating the injury impairment index.
Spicer R, Miller T, Hendrie D, Blincoe L
Ann Adv Automot Med. 2011; 55:365-77.
PMID: 22105411
PMC: 3256815.